	COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer. J Clin Oncol Rocha Lima CMSP, Yothers G, George TJ, Hochster HS, Sanoff HK, Cohen DJ, Guthrie KA, Jacobs SA, Saeed A, Kopetz S, Colangelo LH, Freeman TJ, Cole SW, Khalil M, Devanna S, Zuckerman DS, Hong TS, Henry NL, Ganz PA, Blanke CD, Wolmark N, Overman MJ. PMID: 42525921 [PubMed - as supplied by publisher]
	Dynamic Circulating Tumor DNA Methylation Monitoring Guiding Postoperative Surveillance in Nonmetastatic Colorectal Cancer: A Prospective, Randomized, Phase III FIND Trial. J Clin Oncol Mo S, Zhou C, Ma M, Luo W, Li Y, Lu P, Tang P, Li Y, Ma X, Hu X, Cheng C, Yang J, Zhuo C, Jian J, Yu C, Ding J, Xiong C, Jiang F, Mu R, Lu Z, Yu J, Jin S, Luan J, Li X, Cai S, Zou H, Li Y, Li Q, Liu F, Ding C, Peng J. PMID: 42525894 [PubMed - as supplied by publisher]
	Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PLoS One Khadka S, Thornton JD, Kamal KM, Higa G, Kelly KM, Nduaguba SO. PMID: 42525681 [PubMed - in process]
	Cancer surgical outcome study in Ethiopia: A 7-day multicenter prospective observational cohort study. PLoS One Awedew AF, Tsegaye YA, Ayen AA, Tesifaw FG, Amsalu BT, Getahun AM. PMID: 42525629 [PubMed - in process]
	Treatment of early gastric cancer in Sweden: A nationwide registry-based cohort study. Scand J Surg Maltzman H, Elbe P, Jeremiasen M, Omae M, Baldaque-Silva F, von Seth E, Lindblad M, Klevebro F. PMID: 42525565 [PubMed - as supplied by publisher]
	The role of adhesins of Fusobacterium nucleatum in colorectal cancer - a structural perspective. Gut Microbes Schöpf F, Marongiu GL, Roderer D. PMID: 42525450 [PubMed - in process]
	Genomic Testing Uptake Among Medicare Beneficiaries With Cancer. JAMA Netw Open Kang SY, Zhang R, Kim C, Schwartz MD, Ahn J, Potosky AL, Gresenz CR. PMID: 42525411 [PubMed - indexed for MEDLINE]
	Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study. Int J Clin Pharm Hayashi T, Go M, Kawasumi K, Kawakami K, Matsui R, Fujii H, Miyoshi T, Eto T, Kajizono M, Ohtsubo T, Morioka Y, Yamaguchi K, Ogawa A, Nakashima T, Todo M, Matsuo K. PMID: 42525322 [PubMed - as supplied by publisher]
	Correction: Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy-resection samples. Gastric Cancer Yu D, Xie T, Cheng S, Liu C, Zhang Y, Zhang B, Wang Y, Feng Y, Wang Y, Gao H, Gao E, Wang Y, Shi C, Shen L, Peng Z. PMID: 42525321 [PubMed - as supplied by publisher]
	Trends and burden of colon and rectum cancer attributable to low physical activity in China: a comprehensive analysis from 1990 to 2021. Cancer Causes Control Zhan Z, Chen B, Chen X, Ma N, Zhou S, Xu J, Yang C, Guo Z. PMID: 42525305 [PubMed - indexed for MEDLINE]
	The multifaceted role of SOCS3 in colorectal cancer: molecular mechanisms and clinical implications. Mol Biol Rep Abbasi H, Razi S, Rezaei N. PMID: 42525172 [PubMed - indexed for MEDLINE]
	Improving follow-up of abnormal stool test results used for colorectal cancer screening. Gastrointest Endosc Levin TR, Ciemins E, Dominitz J, Hosseini-Carroll P, Issaka RB, Lieberman D, Merriman N, Shaukat A, Stollman N, Williams KN. PMID: 42524792 [PubMed - as supplied by publisher]
	Prognostic and Predictive Role of Circulating Tumor DNA in Locally Advanced Rectal Cancer Managed With Total Neoadjuvant Therapy: A Systematic Review. Health Sci Rep Bashir F, Bhat QU, Allegakoen J, Shekouh D, Zaiter S. PMID: 42524649 [PubMed - in process]
	Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. Ther Adv Med Oncol So E, Morizane C, Okusaka T. PMID: 42524036 [PubMed]
	Benefit of Linked-Color Imaging in Artificial Intelligence-Assisted Diagnosis of Early Gastric Cancer: A Pilot Study With Propensity Score Adjustment. DEN Open Mohamed AN, Minoda Y, Maruoka R, Suzuki Y, Fukuya H, Tsuru H, Wada M, Tanaka Y, Chinen T, Moriyama T, Ogino H, Ihara E, Ogawa Y. PMID: 42524027 [PubMed - in process]
	Pharmacological Therapies for Bowel Dysfunction After Colorectal Cancer Surgery: A Systematic Review. Adv Pharm Bull Bananzadeh A, Emami SM, Tadayon SMK, Najib Pour N, Shojaei-Zarghani S, Hosseini SV. PMID: 42524011 [PubMed]
	Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report. Front Immunol Li Z, Yi X, Fu J, Liang Y, Zhang S, Yang X, Du Z. PMID: 42523698 [PubMed - indexed for MEDLINE]
	Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Oncol Eze ED, Ntakirutimana L, Terkimbi SD, Walle M, Umar AH, Wondimu DH, Olubiyi MV, Okeke OC, Onaadepo O, Abdulazeez J, Ikwuka DC, Ani EJ, Alagbonsi AI. PMID: 42523690 [PubMed]
	Sedentary behavior and physical activity are longitudinally associated with diurnal cortisol rhythms in individuals up to 1 year after colorectal cancer treatment: A prospective cohort study. Res Sq Frenken KG, Scheer FAJL, Qian J, Bours MJL, Breukink SO, Janssen-Heijnen MLG, Konsten J, Keulen ETP, Bons JAP, Meijer K, Steindorf K, de Vos-Geelen J, Weijenberg MP, Buffart LM, van Roekel EH. PMID: 42523521 [PubMed - in process]
	Expression and Prognostic Value of Serum microRNA- 375 and microRNA- 182 in Correlation with Tissue Immunehistochemical Expression of Related Proteins, Serving as Novel Biomarkers in Colorectal Cancer. Asian Pac J Cancer Prev Aly DM, Mohamed Fteah A, A Elrefaiy M, Sherbiny M, El-Nahas E, Hegab F, Abdo M. PMID: 42522835 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 243090

Page 1 of 12155



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy